top
Search terms
Results 1 - 6 of 6 - ordered by :
Epeuropace

Methods and results We studied anxiety levels in young women (2140 years) referred for unexplained transient loss of consciousness (TLOC), and age-matched female controls with or without past history ...

Europace, CLINICAL RESEARCH, D. Zyśko, M. Szewczuk-Bogusławska, M. Kaczmarek, A.K. Agrawal, J. Rudnicki, J. Gajek, O. Melander, R. Sutton, A. Fedorowski

Date : 01/02/2015 Item size : 227662 bytes
Epeuropace

Patients were divided into five groups: (i) no history of IHD and normal EST (Group 1); (ii) no history of IHD but positive EST (Group 2); (iii) ischaemic heart disease without any acute myocardial ...

Europace, CLINICAL RESEARCH, Roberto Mollo, Alessandro Cosenza, Antonella Spinelli, Ilaria Coviello, Giulia Careri, Irma Battipaglia, Marianna Laurito, Gaetano Pinnacchio, Gaetano A. Lanza, Filippo ...

Date : 01/02/2012 Item size : 217177 bytes
Epeuropace

ArrhythmiasAtrial fibrillationVentricular tachyarrhythmiasEpidemiologyChronic kidney diseaseDialysisHemodialysisDrugsCardiac implantable electrical devicesCardiac resynchronization ...

Europace, EHRA POSITION PAPER, Giuseppe Boriani, Irina Savelieva, Gheorghe-Andrei Dan, Jean Claude Deharo, Charles Ferro, Carsten W. Israel, Deirdre A. Lane, Gaetano La Manna, Joseph Morton, Angel ...

Date : 01/08/2015
Epeuropace

ACTIVE I9 (subgroup) History of atrial fibrillation (sinus rhythm at baseline) Irbesartan/placebo 1730 70 61 4.1 138/82 Secondary prevention (history of AF) Endpoint (committee validated) Advance8 ...

Europace, Atrial fibrillation, Connor A. Emdin, Tom Callender, Jun Cao, Kazem Rahimi

Date : 01/05/2015
Epeuropace

The prevalence of AF has been estimated to be around 5% at 70 years of age and over 10% among octogenarians.1 It leads to an increase in mortality independent of associated cardiovascular disease ...

Europace, Atrial fibrillation, Linda S.B. Johnson, Tord Juhlin, Gunnar Engström, Peter M. Nilsson

Date : 01/02/2014
Epeuropace

Of note, antiarrhythmic effects of ACE inhibitors and ARBs to prevent AF are supported by retrospective analyses of clinical trials including TRACE (Trandolapril Cardiac Evaluation), ValHeFT ...

Europace, Editorial, Andreas Goette

Date : 01/04/2011